PRAX – praxis precision medicines, inc. (US:NASDAQ)
Stock Stats
News
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
A Look At Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Truist Financial Corporation from $500.00 to $700.00. They now have a "buy" rating on the stock.
Form S-8 Praxis Precision Medicin
Form 10-K Praxis Precision Medicin For: Dec 31
Form 8-K Praxis Precision Medicin For: Feb 19
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: PERCEPTIVE ADVISORS LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.